So the first deal by the fund is not with an antibiotic manufacturer needing support in developing the next drug but with " an innovative biotech company" as told by Skinner and that is what ATH is with its 150 zinc chelators including PBT2 targeting not only bacteria but also viruses and perhaps even cancer as was told in the annual report. IMO, now only PBT2 will be discussed, but we do not know how much info there is about the other 150 zinc chelators.
AMR Action Fund: 1st investment in weeks, months, page-8
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 26088337 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 26088337 | 16 |
View Market Depth
| Last trade - 10.11am 16/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable